Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Naba, Alexandra ^a,c   Clauser, Karl R ^b   Mani, D R ^b   Carr, Steven A ^b   Hynes, Richard O ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROPROTEIN;

ANGIOGENESIS; ANIMAL; DISEASE EXACERBATION; EXTRACELLULAR MATRIX; INSULINOMA; ISOTOPE LABELING; METABOLISM; MOUSE; PANCREAS ISLET; PATHOLOGY; PROCEDURES; PROTEOMICS;

ANIMALS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; INSULINOMA; ISLETS OF LANGERHANS; ISOTOPE LABELING; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOMICS;

EID: 85009080332     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40495     Document Type: Article

References (55)

1. WHO Cancer. WHO Available at: http://www.who.int/mediacentre/factsheets/fs297/en/. (Accessed: 26th July 2016).
2. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437 (2013).
3. Lu, P., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395-406 (2012).
4. DeSimone, D. W., Norton, P. A. & Hynes, R. O. Identification and characterization of alternatively spliced fibronectin mRNAs expressed in early Xenopus embryos. Dev. Biol. 149, 357-69 (1992).
5. Hynes, R. O. The extracellular matrix: not just pretty fibrils. Science 326, 1216-9 (2009).
6. Hynes, R. O. & Yamada, K. M. Extracellular Matrix Biology. (Cold Spring Harbor Laboratory Press, 2012).
7. Anastassiades, O. T. & Pryce, D. M. Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis. Br. J. Cancer 29, 232-239 (1974).
8. Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell. Proteomics 11, M111.014647 (2012).
9. Naba, A. et al. The extracellular matrix: Tools and insights for the 'omics' era. Matrix Biol. 49, 10-24 (2016).
10. Naba, A. et al. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer 14, 518 (2014).
11. Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A. & Hynes, R. O. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. eLife 3, e01308 (2014).
12. Oskarsson, T. et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874 (2011).
13. Provenzano, P. P. et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11 (2008).
14. Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786-801 (2014).
15. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute Available at: http://www.cancer.gov/types/ pancreatic/patient/pnet-treatment-pdq#section/-1.
16. Hanahan, D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315, 115-122 (1985).
17. Folkman, J., Watson, K., Ingber, D. & Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61 (1989).
18. Ribatti, D., Nico, B., Crivellato, E., Roccaro, A. M. & Vacca, A. The history of the angiogenic switch concept. Leukemia 21, 44-52 (2007).
19. Cao, Y. et al. Forty-year journey of angiogenesis translational research. Sci. Transl. Med. 3, 114rv3 (2011).
20. Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. 3, 422-33 (2003).
21. Simon-Assmann, P., Orend, G., Mammadova-Bach, E., Spenlé, C. & Lefebvre, O. Role of laminins in physiological and pathological angiogenesis. Int. J. Dev. Biol. 55, 455-465 (2011).
22. Hynes, R. O. Cell-matrix adhesion in vascular development. J. Thromb. Haemost. JTH 5 Suppl 1, 32-40 (2007).
23. Astrof, S. et al. Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol. Cell. Biol. 24, 8662-70 (2004).
24. Murphy, P. A., Begum, S. & Hynes, R. O. Tumor Angiogenesis in the Absence of Fibronectin or Its Cognate Integrin Receptors. Plos One 10 (2015).
25. Gocheva, V. et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556 (2006).
26. Saupe, F. et al. Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model. Cell Rep. 5, 482-492 (2013).
27. Xie, L. et al. Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Proc. Natl. Acad. Sci. USA 108, 9939-9944 (2011).
28. Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000).
29. Jain, R. K. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26, 605-622 (2014).
30. Langlois, B. et al. AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients. Oncotarget 5, 10529-10545 (2014).
31. Li, D.-S., Yuan, Y.-H., Tu, H.-J., Liang, Q.-L. & Dai, L.-J. A protocol for islet isolation from mouse pancreas. Nat. Protoc. 4, 1649-1652 (2009).
32. Naba, A., Clauser, K. R. & Hynes, R. O. Enrichment of extracellular matrix proteins from tissues and digestion into peptides for mass spectrometry analysis. J. Vis. Exp. 101, e53057 (2015).
33. Ow, S. Y. et al. iTRAQ underestimation in simple and complex mixtures: 'the good, the bad and the ugly'. J. Proteome Res. 8, 5347-5355 (2009).
34. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).
35. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. gkv007, doi: 10.1093/nar/gkv007 (2015).
36. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289-300 (1995).
37. Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 11, 367 (2010).
38. McDonald, D. M. & Baluk, P. Significance of Blood Vessel Leakiness in Cancer. Cancer Res. 62, 5381-5385 (2002).
39. Iozzo, R. V. & Sanderson, R. D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 15, 1013-1031 (2011).
40. Neill, T., Schaefer, L. & Iozzo, R. V. Decorin as a multivalent therapeutic agent against cancer. Adv. Drug Deliv. Rev. 97, 174-185 (2016).
41. Motomura, K. et al. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome. J. Neuropathol. Exp. Neurol. 71, 702-707 (2012).
42. Takeshita, H. et al. Expression of the DMBT1 gene is frequently suppressed in human lung cancer. Jpn. J. Cancer Res. Gann 90, 903-908 (1999).
43. Mori, M. et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br. J. Cancer 79, 211-213 (1999).
44. Pang, J. C.-S. et al. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int. J. Cancer 105, 76-81 (2003).
45. Joyce, J. A. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443-453 (2004).
46. Okamoto, H. The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells. J. Hepatobiliary. Pancreat. Surg. 6, 254-262 (1999).
47. Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387 (2014).
48. Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 (2016).
49. Zhang, H. et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell 166, 755-765 (2016).
50. Jonkers, Y. M. H., Ramaekers, F. C. S. & Speel, E. J. M. Molecular alterations during insulinoma tumorigenesis. Biochim. Biophys. Acta BBA-Rev. Cancer 1775, 313-332 (2007).
51. Oberg, K. Pancreatic endocrine tumors. Semin. Oncol. 37, 594-618 (2010).
52. Veiseh, O., Tang, B. C., Whitehead, K. A., Anderson, D. G. & Langer, R. Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug Discov. 14, 45-57 (2015).
53. Pagliuca, F. W. & Melton, D. A. How to make a functional ß-cell. Dev. Camb. Engl. 140, 2472-2483 (2013).
54. Stendahl, J. C., Kaufman, D. B. & Stupp, S. I. Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant. 18, 1-12 (2009).
55. Dolenšek, J., Rupnik, M. S. & Stožer, A. Structural similarities and differences between the human and the mouse pancreas. Islets 7, e1024405 (2015).